Cited 10 time in
3D-printed tablets using a single-step hot-melt pneumatic process for poorly soluble drugs
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Seong Jun | - |
| dc.contributor.author | Lee, Jae Chul | - |
| dc.contributor.author | Ko, Jin Young | - |
| dc.contributor.author | Lee, Seon Ho | - |
| dc.contributor.author | Kim, Nam Ah | - |
| dc.contributor.author | Jeong, Seong Hoon | - |
| dc.date.accessioned | 2024-08-08T09:30:43Z | - |
| dc.date.available | 2024-08-08T09:30:43Z | - |
| dc.date.issued | 2021-02-15 | - |
| dc.identifier.issn | 0378-5173 | - |
| dc.identifier.issn | 1873-3476 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/20894 | - |
| dc.description.abstract | Main purpose was to evaluate the applicability of a 3D-printer equipped with a hot-melt pneumatic dispenser as a single-step process to prepare tablet dosage forms. Dutasteride, a poorly water-soluble drug, was selected as a model drug. Soluplus (R), Kollidon (R) VA 64, Eudragit (R) E PO, and hydroxypropyl cellulose (HPC) were premixed as bulking agents prior to printing. Differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), and thermogravimetric analysis (TGA) were utilized to evaluate the physicochemical properties of the 3D-printed tablets. Moreover, different geometries were designed to correlate the surface area/volume (SA/V) of the tablets with respect to their release profiles. As a result, printed dutasteride was confirmed to be in an amorphous state and not recrystallized even after the accelerated storage stability. Out of the four bulking agents, Kollidon (R) VA 64, enhanced the dissolution of the printed dutasteride, reaching above 80% within 15 min. These results suggest that the hot-melt pneumatic dispenser was efficient in converting the solid state into an amorphous state, which significantly enhanced the dissolution. On the other hand, the tube-shaped 3D-printed tablet exhibited the fastest drug dissolution profile, which had the highest SA/V ratio in comparison to the cube, hemisphere, and pyramid shapes. These results confirm the dependency of the drug dissolution rate not only on its crystallinity but also on the surface area of the 3D-printed tablet. Therefore, a 3D-printer equipped with a hot-melt pneumatic dispenser possesses useful applicability in enhancing drug dissolution, especially for poorly water-soluble drugs, in a single-step process. | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | ELSEVIER | - |
| dc.title | 3D-printed tablets using a single-step hot-melt pneumatic process for poorly soluble drugs | - |
| dc.type | Article | - |
| dc.publisher.location | 네델란드 | - |
| dc.identifier.doi | 10.1016/j.ijpharm.2021.120257 | - |
| dc.identifier.scopusid | 2-s2.0-85100299962 | - |
| dc.identifier.wosid | 000615977600013 | - |
| dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF PHARMACEUTICS, v.595 | - |
| dc.citation.title | INTERNATIONAL JOURNAL OF PHARMACEUTICS | - |
| dc.citation.volume | 595 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordAuthor | 3D-printer | - |
| dc.subject.keywordAuthor | Pneumatic | - |
| dc.subject.keywordAuthor | Poorly water-soluble | - |
| dc.subject.keywordAuthor | Amorphous | - |
| dc.subject.keywordAuthor | Surface area | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
